BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18482337)

  • 21. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The three-dimensional structure of the bifunctional 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase/dihydropteroate synthase of Saccharomyces cerevisiae.
    Lawrence MC; Iliades P; Fernley RT; Berglez J; Pilling PA; Macreadie IG
    J Mol Biol; 2005 May; 348(3):655-70. PubMed ID: 15826662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular models of tryptophan synthase from mycobacterium tuberculosis complexed with inhibitors.
    Dias MV; Canduri F; da Silveira NJ; Czekster CM; Basso LA; Palma MS; Santos DS; de Azevedo WF
    Cell Biochem Biophys; 2006; 44(3):375-84. PubMed ID: 16679524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
    ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
    Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
    Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the bound conformation of a competitive nanomolar inhibitor of mycobacterium tuberculosis type II dehydroquinase by NMR spectroscopy.
    Prazeres VF; Sánchez-Sixto C; Castedo L; Canales A; Cañada FJ; Jiménez-Barbero J; Lamb H; Hawkins AR; González-Bello C
    ChemMedChem; 2006 Sep; 1(9):990-6. PubMed ID: 16952136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
    Giordanetto F; Fowler PW; Saqi M; Coveney PV
    Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidation of Mycobacterium tuberculosis type II dehydroquinase inhibitors using a fragment elaboration strategy.
    Tran AT; West NP; Britton WJ; Payne RJ
    ChemMedChem; 2012 Jun; 7(6):1031-43. PubMed ID: 22461418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
    Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
    ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery.
    Kumar M; Vijayakrishnan R; Subba Rao G
    Mol Divers; 2010 Aug; 14(3):595-604. PubMed ID: 19697148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
    Schmidt MF; Korb O; Howard NI; Dias MV; Blundell TL; Abell C
    ChemMedChem; 2013 Jan; 8(1):54-8. PubMed ID: 23169689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
    El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of Mycobacterium tuberculosis dUTpase: docking and catalytic mechanism studies.
    Ramalho TC; Caetano MS; Josa D; Luz GP; Freitas EA; da Cunha EF
    J Biomol Struct Dyn; 2011 Jun; 28(6):907-17. PubMed ID: 21469751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
    Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
    J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
    Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.